Last reviewed · How we verify
NCT06118242
The Effect of Solutions Used in Oral Care on Preventing Ventilator-Associated Pneumonia.
NA trial testing Use of oral care solutions in Ventilator-Associated Pneumonia in 105 participants. Status unknown.
15 November 2024
Quick facts
| Lead sponsor | Aydin Adnan Menderes University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 105 |
| Start date | 15 November 2023 |
| Primary completion | 15 November 2024 |
| Estimated completion | 15 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Use of oral care solutions
Conditions studied
- Ventilator-Associated Pneumonia — all drugs for Ventilator-Associated Pneumonia →
Sponsor
Aydin Adnan Menderes University
Who can join
18 and older, any sex, with Ventilator-Associated Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn about effects of chlorhexidine gluconate, sodium bicarbonate, ozonated water and hypochlorous acid solutions used in oral care of patients on mechanical ventilation support on preventing ventilator associated pneumonia. The main question\[s\] it aims to answer are: Is there any difference between 1% chlorhexidine gluconate, sodium bicarbonate, ozonated water and hypochlorous acid solutions versus 0.12% chlorhexidine gluconate solution used in oral care in preventing the development of VAP? Is there any difference between 1% chlorhexidine gluconate, sodium bicarbonate, ozonated water and hypochlorous acid solutions versus 0.12% chlorhexidine gluconate solution used in oral care in preventing the development of VAP? Researchers will compare 1% chlorhexidine gluconate, sodium bicarbonate, ozonated water and hypochlorous acid solutions to see if VAP
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06118242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ventilator-Associated Pneumonia
Currently open trials in the same condition.
- NCT07013032 — Diagnostic and Prognostic Value of Reticulated Platelet Fraction in Ventilator-Associated Pneumonia (REPLAY-VAP) · recruiting
Other Aydin Adnan Menderes University trials
Trials by the same sponsor.
- NCT07535151 — The Study Aims to Determine the Effect of Using Animal-shaped Magic Mirrors During Vaccination in Children Aged 1-4 Year · not yet recruiting
- NCT07448246 — Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery · NA · recruiting
- NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
- NCT07121699 — The Role of Left Ventricular Outflow Tract (LVOT) Velocity-time Integral (VTI) and Respiratory Variability at Peak Rate · not yet recruiting
- NCT07044739 — Information on the Use of Anti-embolic Stockings in Patients Undergoing Vein Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06118242 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aydin Adnan Menderes University
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06118242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing